These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25131727)

  • 1. Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.
    Buckland B; Boulanger R; Fino M; Srivastava I; Holtz K; Khramtsov N; McPherson C; Meghrous J; Kubera P; Cox MM
    Vaccine; 2014 Sep; 32(42):5496-502. PubMed ID: 25131727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FluBlok, a next generation influenza vaccine manufactured in insect cells.
    Cox MM; Hollister JR
    Biologicals; 2009 Jun; 37(3):182-9. PubMed ID: 19297194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
    King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
    Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
    Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells.
    Meghrous J; Khramtsov N; Buckland BC; Cox MM; Palomares LA; Srivastava IK
    Biotechnol Bioeng; 2015 Nov; 112(11):2267-75. PubMed ID: 25943562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel recombinant influenza vaccine in insect cells.
    McPherson CE
    Biologicals; 2008 Nov; 36(6):350-3. PubMed ID: 18804387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insect larvae biofactories as a platform for influenza vaccine production.
    Gomez-Casado E; Gomez-Sebastian S; Núñez MC; Lasa-Covarrubias R; Martínez-Pulgarín S; Escribano JM
    Protein Expr Purif; 2011 Sep; 79(1):35-43. PubMed ID: 21421054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.
    Wang K; Holtz KM; Anderson K; Chubet R; Mahmoud W; Cox MM
    Vaccine; 2006 Mar; 24(12):2176-85. PubMed ID: 16310896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant expression systems for production of hemagglutinin as a vaccine against influenza virus.
    Redkiewicz P; Sirko A; Kamel KA; Góra-Sochacka A
    Acta Biochim Pol; 2014; 61(3):551-60. PubMed ID: 25203219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fast track influenza virus vaccine produced in insect cells.
    Cox MM; Hashimoto Y
    J Invertebr Pathol; 2011 Jul; 107 Suppl():S31-41. PubMed ID: 21784229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of a novel influenza vaccine using insect cells: protection against drifted strains.
    Cox MM; Karl Anderson D
    Influenza Other Respir Viruses; 2007 Jan; 1(1):35-40. PubMed ID: 19453478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.
    Creskey MC; Li C; Wang J; Girard M; Lorbetskie B; Gravel C; Farnsworth A; Li X; Smith DG; Cyr TD
    Vaccine; 2012 Jul; 30(32):4762-70. PubMed ID: 22643214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production.
    Sequeira DP; Correia R; Carrondo MJT; Roldão A; Teixeira AP; Alves PM
    Vaccine; 2018 May; 36(22):3112-3123. PubMed ID: 28291648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development and manufacture of influenza vaccines.
    Buckland BC
    Hum Vaccin Immunother; 2015; 11(6):1357-60. PubMed ID: 25844949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the hemagglutinin HA1 subunit of the equine influenza virus using a baculovirus expression system.
    Sguazza GH; Fuentealba NA; Tizzano MA; Galosi CM; Pecoraro MR
    Rev Argent Microbiol; 2013; 45(4):222-8. PubMed ID: 24401775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin.
    Schwarzer J; Rapp E; Hennig R; Genzel Y; Jordan I; Sandig V; Reichl U
    Vaccine; 2009 Jul; 27(32):4325-36. PubMed ID: 19410619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
    Sączyńska V
    Acta Biochim Pol; 2014; 61(3):561-72. PubMed ID: 25195143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
    Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
    Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological evaluation of vector-expressed M2 and HA genes of H5N1 influenza virus in mice].
    Guo J; Yao L; Chen A; Xu Y; Liu X; Shu Y; Zhang Z
    Sheng Wu Gong Cheng Xue Bao; 2010 May; 26(5):649-56. PubMed ID: 20684310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.